People · Operator
Named in public records as an officer, director or promoter · active 2012–2021 · Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Declarative Holdings, Inc. | — | Other Technology | Series B | $77.0M | $106.6M | 2012 |
| Xcell Biosciences, Inc. | — | Biotechnology | Series B | $28.4M | $8.3M | 2017 |
James Lim at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James Lim on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jonathan Hallett | 1 | 10 |
| John Siegel | 1 | 9 |
| Jason Booma | 1 | 6 |
| David Northington | 1 | 5 |
| Saeid Akhtari | 1 | 3 |
| Jonathan Hallet | 1 | 1 |
| Chris Arroyo | 1 | 1 |
| Saeid S. Akhtari | 1 | 1 |
| James S. Lim | 1 | 1 |
| Kaz S. Ohno | 1 | 1 |
| Brian S. Feth | 1 | 1 |
| Kaz Ohno | 1 | 1 |
| Brian Feth | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.